Figure 3.
Plasma creatine kinase concentration (U/L; A), plasma interleukin 6 concentration (pg/mL; B), homeostatic model of assessment insulin resistance (HOMA-IR; C) and muscle soreness rating (mm; D). ** indicates significant main time effect from baseline (p ≤ 0.01); * indicates significant main time effect from baseline (p ≤ 0.05); # indicates significantly different from all other time points (p ≤ 0.01).